Photocure ASA - Notice of the Annual General Meeting 23 May 2024
The notice convening the general meeting, including the agenda and the board's proposals to the matters to be dealt with, is enclosed with this notification and will be sent to all shareholders with known addresses.
Relevant documents referred to in the notice are made available on
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000
Email: About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at
www.hexvix.com or
www.cysview.com.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:
